|
Volumn 11, Issue 12, 2011, Pages 1420-
|
Editorial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
11BETA HYDROXYSTEROID DEHYDROGENASE 1;
ANTIDIABETIC AGENT;
ANTIOBESITY AGENT;
CANNABINOID 1 RECEPTOR;
CANNABINOID 1 RECEPTOR ANTAGONIST;
DAPAPGLIFLOZIN;
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON;
GLUCOSE;
INSULIN;
SODIUM GLUCOSE COTRANSPORTER 1;
SODIUM GLUCOSE COTRANSPORTER 2;
UNCLASSIFIED DRUG;
HISTAMINE H3 RECEPTOR;
RIMONABANT;
ABDOMINAL OBESITY;
ADIPOSE TISSUE;
APPETITE;
BINDING AFFINITY;
BIOLOGICAL ACTIVITY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CRYSTAL STRUCTURE;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG TARGETING;
EDITORIAL;
FOOD INTAKE;
GLUCAGON RELEASE;
GLUCOSE BLOOD LEVEL;
GLUCOSE HOMEOSTASIS;
GLUCOSE INTOLERANCE;
GLUCOSURIA;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERCORTISOLISM;
HYPERINSULINEMIA;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
IN VIVO STUDY;
INSULIN RELEASE;
INSULIN RESISTANCE;
LONG TERM CARE;
METABOLIC DISORDER;
METABOLIC SYNDROME X;
NEUROENDOCRINE SYSTEM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OBESITY;
PHARMACODYNAMICS;
STOMACH EMPTYING;
STRUCTURE ACTIVITY RELATION;
WEIGHT CONTROL;
WEIGHT REDUCTION;
BLOOD GLUCOSE MONITORING;
COGNITIVE DEFECT;
DRUG RECALL;
PHARMACOPHORE;
PROTEIN DEGRADATION;
TISSUE DISTRIBUTION;
HUMANS;
METABOLIC SYNDROME X;
|
EID: 84855183851
PISSN: 15680266
EISSN: 18734294
Source Type: Journal
DOI: 10.2174/156802611795860960 Document Type: Editorial |
Times cited : (1)
|
References (0)
|